NVP Associates
Latest statistics and disclosures from NVP Associates's latest quarterly 13F-HR filing:
- Top 5 stock holdings are DAVE, TALK, MBX, UDMY, ZBIO, and represent 94.23% of NVP Associates's stock portfolio.
- Reduced shares in these 1 stock: DBGI.
- Sold out of its position in DBGI.
- NVP Associates was a net seller of stock by $-214.014000.
- NVP Associates has $187M in assets under management (AUM), dropping by 6.12%.
- Central Index Key (CIK): 0001545692
Tip: Access up to 7 years of quarterly data
Positions held by NVP Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for NVP Associates
NVP Associates holds 7 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Dave Class A Com New (DAVE) | 27.1 | $51M | 583k | 86.92 |
|
|
| Talkspace (TALK) | 24.3 | $45M | 15M | 3.09 |
|
|
| Mbx Biosciences (MBX) | 21.1 | $39M | 2.1M | 18.43 |
|
|
| Udemy (UDMY) | 13.7 | $26M | 3.1M | 8.23 |
|
|
| Zenas Biopharma (ZBIO) | 8.1 | $15M | 1.8M | 8.19 |
|
|
| Opendoor Technologies (OPEN) | 3.6 | $6.7M | 4.2M | 1.60 |
|
|
| Grove Collaborative Hold Com Cl A (GROV) | 2.2 | $4.1M | 2.9M | 1.39 |
|
Past Filings by NVP Associates
SEC 13F filings are viewable for NVP Associates going back to 2022
- NVP Associates 2024 Q4 filed Feb. 10, 2025
- NVP Associates 2024 Q3 filed Nov. 12, 2024
- NVP Associates 2024 Q2 filed Aug. 13, 2024
- NVP Associates 2024 Q1 filed May 10, 2024
- NVP Associates 2023 Q4 filed Feb. 14, 2024
- NVP Associates 2023 Q3 filed Nov. 8, 2023
- NVP Associates 2023 Q2 filed Aug. 1, 2023
- NVP Associates 2023 Q1 filed May 15, 2023
- NVP Associates 2022 Q4 filed Feb. 14, 2023